Glucose and fructose levels were 30 per cent higher after researchers removed two genes that regulate sugar content, ...

Gene mutations have consequences both good and bad—from resistance to conditions like diabetes to susceptibility to certain ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Genome Editing Market Size Was Valued at USD 7.39 Billion in 2023, and is Projected to Reach USD 30.78 Billion by 2032, ...

AmpliTech Inc, the core division of AmpliTech Group, founded in 2002, Amplitech Inc, has proprietary low noise technology ...

ZUG, Switzerland and BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRSP), a biopharmaceutical company focused on ...

By knocking out two specific genes using the CRISPR-Cas9 tool, the scientists achieved an increase in glucose and fructose ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

Yoko Ono is the fully entitled owner of a watch given to John Lennon two months before his murder. The Swiss Federal Court has rejected an appeal by a collector against a decision by the Geneva court ...

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, ...

CRISPR Therapeutics(NASDAQ: CRSP) is redefining medicine through its groundbreaking gene editing technology. The company has achieved a historic milestone by securing the first-ever approval for a ...

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...